Imagined Ugliness Can be Treated with Internet-Based CBT

Imagined ugliness, or body dysmorphic disorder (BDD) as it is known, can be treated with internet-based CBT, according to a recent randomised study, the first of its kind ever conducted. The new treatment, which is published in the British Medical Journal (BMJ), has been developed by researchers at Sweden's Karolinska Institutet and has the potential to increase access to care for sufferers of BDD.

People suffering from BDD have a preoccupation with perceived flaws in one's physical appearance, despite looking normal. However, even though the diagnosis is associated with an elevated risk of suicide, higher rate of sick leave and considerable distress, BDD has long been neglected by the care services, leaving sufferers struggling to find the help they need.

In order to increase access to therapy, a new type of internet-based cognitive behavioural therapy (CBT) has been developed and tested in the largest treatment study to date. After twelve weeks' of treatment, one in every three patients no longer met criteria for a diagnosis of BDD.

"Our results show that internet-based CBT outperformed supportive therapy, and that its therapeutic effect is fully comparable with that achieved by conventional CBT," says the study's first author Jesper Enander at Karolinska Institutet's Department of Clinical Neuroscience.

A majority of the 94 patients included in the study had been suffering from BDD for many years and had had previous contact with the healthcare services. One in five had undergone one to six plastic surgery operations trying to 'fix' perceived flaws in their appearance. For the study, the group was randomly assigned to two forms of therapy: internet-based CBT or supportive therapy. Those assigned to this latter control group were later offered CBT.

Immediately after the therapy programme ended, half of the people in the CBT group showed greatly reduced symptoms. One third were completely cured. CBT also improved the participants’ quality of life and reduced depressive symptoms. Of the participants who had major depressive disorder at the start of the study, half were no longer depressed at the end of the study.

The researchers hope that the treatment will eventually be made generally available, so that more BDD sufferers can get access to treatment that works.

"Many BDD suffers receive no treatment at all, partly because the condition is relatively unknown within the healthcare services but also because people with the disorder tend not to seek treatment out of fear that they'll be dismissed as superficial or not be taken seriously," says principal investigator Christian Rück at Karolinska Institutet's Department of Clinical Neuroscience. "Most of the study participants also said it was the possibility to do the therapy online that made them seek any help at all in the first place."

The study was financed by ALF funds from Karolinska Institutet and the Stockholm County Council, the Swedish Research Council and the Swedish Society of Medicine.

Therapist-guided Internet-based cognitive behavioural therapy for body dysmorphic disorder: A single-blind randomised controlled trial, Jesper Enander, Erik Andersson, David Mataix-Cols, Linn Lichtenstein, Katarina Alström, Gerhard Andersson, Brjánn Ljótsson, Christian Rück, British Medical Journal , BMJ 2016;352:i24, online 2 February 2016.

Karolinska Institutet is one of the world's leading medical universities. Its vision is to significantly contribute to the improvement of human health. Karolinska Institutet accounts for over 40 per cent of the medical academic research conducted in Sweden and offers the country's broadest range of education in medicine and health sciences. The Nobel Assembly at Karolinska Institutet selects the Nobel laureates in Physiology or Medicine.

Most Popular Now

Philips Foundation 2024 Annual Report: E…

Marking its tenth anniversary, Philips Foundation released its 2024 Annual Report, highlighting a year in which the Philips Foundation helped provide access to quality healthcare for 46.5 million people around...

New AI Transforms Radiology with Speed, …

A first-of-its-kind generative AI system, developed in-house at Northwestern Medicine, is revolutionizing radiology - boosting productivity, identifying life-threatening conditions in milliseconds and offering a breakthrough solution to the global radiologist...

Scientists Argue for More FDA Oversight …

An agile, transparent, and ethics-driven oversight system is needed for the U.S. Food and Drug Administration (FDA) to balance innovation with patient safety when it comes to artificial intelligence-driven medical...

New Research Finds Specific Learning Str…

If data used to train artificial intelligence models for medical applications, such as hospitals across the Greater Toronto Area, differs from the real-world data, it could lead to patient harm...

Giving Doctors an AI-Powered Head Start …

Detection of melanoma and a range of other skin diseases will be faster and more accurate with a new artificial intelligence (AI) powered tool that analyses multiple imaging types simultaneously...

AI Agents for Oncology

Clinical decision-making in oncology is challenging and requires the analysis of various data types - from medical imaging and genetic information to patient records and treatment guidelines. To effectively support...

Patients say "Yes..ish" to the…

As artificial intelligence (AI) continues to be integrated in healthcare, a new multinational study involving Aarhus University sheds light on how dental patients really feel about its growing role in...

Brains vs. Bytes: Study Compares Diagnos…

A University of Maine study compared how well artificial intelligence (AI) models and human clinicians handled complex or sensitive medical cases. The study published in the Journal of Health Organization...

'AI Scientist' Suggests Combin…

An 'AI scientist', working in collaboration with human scientists, has found that combinations of cheap and safe drugs - used to treat conditions such as high cholesterol and alcohol dependence...

Start-ups in the Spotlight at MEDICA 202…

17 - 20 November 2025, Düsseldorf, Germany. MEDICA, the leading international trade fair and platform for healthcare innovations, will once again confirm its position as the world's number one hotspot for...